Institutional investors purchased a net $762.1 thousand shares of CYTR during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 31.89% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RAMIUS ADVISORS LLC Bought 321.4 Thousand shares of CytRx Corp